SHINIL PHARMACEUTICAL CO., LTD. financial statements, including revenue, expenses, profit, and loss

The total revenue of 012790 for the last quarter is 24.50 B KRW, and it's 7.61% higher compared to the previous quarter. The net income of Q2 24 is 3.95 B KRW.